Transmedics
TMDX
340 hedge funds and large institutions have $5.09B invested in Transmedics in 2024 Q2 according to their latest regulatory filings, with 107 funds opening new positions, 97 increasing their positions, 116 reducing their positions, and 27 closing their positions.
296% more first-time investments, than exits
New positions opened: 107 | Existing positions closed: 27
172% more call options, than puts
Call options by funds: $66.5M | Put options by funds: $24.5M
150% more funds holding in top 10
Funds holding in top 10: 6 → 15 (+9)
102% more capital invested
Capital invested by funds: $2.52B → $5.09B (+$2.57B)
29% more funds holding
Funds holding: 263 → 340 (+77)
1.65% less ownership
Funds ownership: 104.21% → 102.56% (-1.6%)
16% less repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 116
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$76.4M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$37.9M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$37.7M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$32.4M |
| 5 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$31.7M |
Top Sellers
TMDX Hedge Fund Activity: Q2 2024 in Review
340 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q2 2024, worth a combined $5.09B — up 102% from $2.52B a quarter earlier.
Buyers outnumbered sellers: 107 funds opened new TMDX positions and 27 closed out — a net gain of 80 holders — while 97 added to existing stakes and 116 trimmed.
The largest buyer was Vanguard Group, adding an estimated $76.4M. The largest seller was Braidwell, cutting an estimated $50.9M.
- 340 institutional investors held Transmedics (TMDX) as of Q2 2024, up from 263 in Q1 2024.
- Funds reported $5.09B of Transmedics stock for Q2 2024, up 102% quarter-over-quarter.
- 107 funds opened new Transmedics positions in Q2 2024 and 27 closed out, a net change of +80 holders.
- The largest Transmedics buyer in Q2 2024 was Vanguard Group, an estimated $76.4M added.
- The largest Transmedics seller in Q2 2024 was Braidwell, an estimated $50.9M sold.
Based on aggregated 13F filings for Q2 2024.